FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/07/2022
Back to search
Official data from USPTO
NAOBIOS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NAOBIOS
ST13
US500000079316582Class
5, 10, 41, 42, 44
Filing
79316582
Registration
6776931
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
11/07/2022
Trademark type
Word
Nice classes
5, 10, 41, 42, 44
Filing date
01/07/2021
Registration date
07/05/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/05/2022
Last transaction
07/05/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
FR
Examiner
ORNDORFF, LINDA
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NAOBIOS
Representatives
Joseph Sofer IPSILON USA
Technical classification
Nice Classes
Class 5Class 10Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical and biochemical reagents for medical and pharmaceutical use; biological reagentsbiological preparations for detectionanalysis and quantification of microbial contaminants for medical diagnostic purposes for research; chemical reagents and culture media for medical and pharmaceutical diagnostics; medical diagnostic testing strips and reagents for testing for the presence of pathogens and infections; medical diagnostic kits comprising medical diagnostic test strips and reagents for testing for the presence of pathogens and infections; medical diagnostic kits comprising medical diagnostic test strips and reagents for analyzing organic liquids of microorganisms
Class 10
Diagnostic sample preparations devices for medical use for detection of virusesbacteriafungipathogens and parasites; Medical diagnostic apparatus and analytical apparatus for biological sample analysis for medical diagnostic purposes; diagnostic kits consisting primarily of probesbuffers and reagents for use in microbial testing for medical use for detection of virusesbacteriafungipathogens and parasites; Medical instruments for analysing for identification of bacteria for medical use
Class 41
Training in the field of healthbiotechnologybiomedicinebacteriology and bioproduction; conducting workshops and seminars in the field of healthbiotechnologybiomedicinebacteriology and bioproduction; provision of online training in the form of coursesseminarsworkshopswebinar in the field of healthbiotechnologybiomedicinebacteriology and bioproduction; provision of online non-downloadable educational materials in the nature of booksmagazinesbrochuresjournalsnewsletters in the field of health; provision of non-downloadable online electronic publications in the nature of booksmagazinesbrochuresjournalsnewsletters in the field of healthbiotechnologybiomedicinebacteriology and bioproduction
Class 42
Medical research; biological research; scientific research; research in bacteriology; research in biochemistry; research in biotechnology; research in the field of pharmaceutical products; pharmaceutical research and development; research and development for the pharmaceutical industry; scientific and medical research and development; Pharmaceuticalbiomedicalagrochemicalchemicalbacteriological research services in the field of proteinsantibodiesmicroorganisms and cells; scientific laboratory services relating to the isolation and cultivation of human tissues and cells; scientific research and development in the field of microorganisms and cells; stem cell research services; research and development of vaccines and medicines; research and testing in bacteriology; research and development services in the field of antibody technology; provision of information relating to medical and scientific research in the field of pharmaceutical products; Scientific and technological servicesresearchtesting and analysis in the field of biotechnologybiomedicinebacteriology and bioproduction; consultancy with respect to pharmaceutical research and development; provision of information regarding medical and scientific research in the field of pharmaceutical products and clinical trials; quality control for others; quality management servicesquality evaluation and analysisquality assurancequality controlin the field of biotechnologybiomedicinebacteriology and bioproduction; scientific research in the field of gene therapy; testinganalysis and evaluation of services for third parties to determine compliance with certification standards; development of medicines including production of raw materials used for producing medicines; development of biological medicines including production of raw materials
Class 44
Biomedical servicesthe Storage of human cells for medical purposes; stem cell bank services; biomedical servicesthe storage of human cells for medical usestem cell bank services storage of tissuescells and cellular components for medical and scientific use; stem cell bank servicesstorage of human cellscell components and tissues intended for cell and cell component treatments and transplantations; cell bank services; Human tissue analysis services for medical treatments; genetic testing for medical purposes; Performing diagnosis of diseases; genetic analysis for medical use; stem cell bank servicesstorage of human cellscell banksviral batches and all derived biological products
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/14/2022
FIMP
FINAL DISPOSITION PROCESSED
10/14/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/05/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/05/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
07/05/2022
GPNX
NOTIFICATION PROCESSED BY IB
05/03/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/19/2022
PUBO
PUBLISHED FOR OPPOSITION
04/19/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/13/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/13/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/30/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/15/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/16/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/16/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/16/2022
RFNT
REFUSAL PROCESSED BY IB
09/05/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/16/2021
RFRR
REFUSAL PROCESSED BY MPU
08/16/2021
MAFR
APPLICATION FILING RECEIPT MAILED
08/06/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/04/2021
CNRT
NON-FINAL ACTION WRITTEN
08/03/2021
DOCK
ASSIGNED TO EXAMINER
08/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/02/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/29/2021
Continuous trademark protection
Get notified about every new filing that threatens NAOBIOS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.